Address
Email address
Phone number
Name
Sihtasutus Kõrva-Nina-Kurguhaiguste Kliinik
Registry code
90008421
VAT number
EE101249346
Type
SA - Foundation
Status
Registered
Foundation date
29.03.2004 (21)
Financial year
01.01-31.12
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Oliver Vaide
| - | Board member | - | Founder |
| Sven Kivioja
| - | Board member | - | Founder |
| Piret Klaan
| - | - | - | Board member |
| Kristjan Kenapea
| - | - | - | Chairman of the board |
| Aet Saarts
| - | - | - | Founder |
| Aime Jesse
| - | - | - | Founder |
| Aino Allivere
| - | - | - | Founder |
| Annika Jussi
| - | - | - | Founder |
| Dmitri Dubrovin
| - | - | - | Founder |
| Ene Miller
| - | - | - | Founder |
| Kristel Kalling
| - | - | - | Founder |
| Liina Luht
| - | - | - | Founder |
| Mare Kalvet
| - | - | - | Founder |
| Marek Metsmaa
| - | - | - | Founder |
| Piibe Laane
| - | - | - | Founder |
| Reet Ani
| - | - | - | Founder |
| Urve Lekk
| - | - | - | Founder |
| Valdeko Pallav
| - | - | - | Founder |
| Ülle Kirss
| - | - | - | Founder |
| Margus Luht
| - | - | - | FounderBoard member |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 164 875.29 € | 207 924.77 € | 209 830.39 € | 37 |
| 2024 Q3 | 84 237.06 € | 270 584.64 € | 269 932.9 € | 39 |
| 2024 Q2 | 108 283.84 € | 192 320.07 € | 199 350.34 € | 39 |
| 2024 Q1 | 116 189.31 € | 245 466.23 € | 242 314.62 € | 36 |
| 2023 Q4 | 187 077.33 € | 212 115.67 € | 207 195.35 € | 37 |
| 2023 Q3 | 76 628.73 € | 176 055.59 € | 180 588.34 € | 32 |
| 2023 Q2 | 153 714.55 € | 199 048.57 € | 204 519 € | 33 |
| 2023 Q1 | 120 645.26 € | 152 666.63 € | 156 137.88 € | 32 |
| 2022 Q4 | 119 824.18 € | 127 879.47 € | 131 165.73 € | 32 |
| 2022 Q3 | 66 111.8 € | 116 139.79 € | 118 250.98 € | 30 |
| 2022 Q2 | 102 135.28 € | 108 580.46 € | 115 052.93 € | 30 |
| 2022 Q1 | 100 779.53 € | 143 744.59 € | 145 402.86 € | 31 |
| 2021 Q4 | 72 347.96 € | 108 195.87 € | 112 827.79 € | 31 |
| 2021 Q3 | 38 104.32 € | 121 885.6 € | 127 933.92 € | 31 |
| 2021 Q2 | 32 469.85 € | 91 662.39 € | 96 789.46 € | 31 |
| 2021 Q1 | 35 857.85 € | 116 052.23 € | 120 867.16 € | 38 |
| 2020 Q4 | 48 171.76 € | 95 533.66 € | 100 174.68 € | 38 |
| 2020 Q3 | 33 194.39 € | 95 126.7 € | 98 703.51 € | 36 |
| 2020 Q2 | 21 956.16 € | 89 860.58 € | 92 492.13 € | 35 |
| 2020 Q1 | 41 422.34 € | 134 472.13 € | 138 953.39 € | 35 |
